25-09-2023; Mauritius. Mediterrania Capital Partners, a Private Equity firm focused on growth investments for SMEs and mid-cap companies in North Africa and Sub-Saharan countries, is pleased to announce that Cassa Depositi e Prestiti S.p.A. (CDP Group) will be investing €20 million in the new MC IV fund to support mid-cap companies in...
21-09-2023; Mauritius. Mediterrania Capital Partners, a Private Equity firm focused on growth investments for SMEs and mid-cap companies in North Africa and Sub-Saharan countries, is pleased to announce that the EBRD will be investing up to €30 million in the new MC IV fund to support mid-cap companies in North and Sub-Saharan...
12-07-2023; The Ministry of International Cooperation
In the same context, the bank approved a new financing for the Mediterrania Capital IV Fund worth €30.2 million, equivalent to $32.5 million. The fund aims to direct investments of €350 million in investments for medium-sized companies in the health care, retail, financial services and manufacturing sectors to develop the economy in Egypt, Tunisia and Morocco, paying special attention to companies led by women to enhance their access to the necessary economic opportunities.
14-05-2023; Challenge MA
L’ouverture de capital de l’un des leaders marocains de l’industrie pharmaceutique que nous avions annoncée, est effective. Laprophan, propriété exclusive de la famille Bennis depuis 75 ans, reçoit un investissement de 75 millions d’euros de la part d’une cohorte d’investisseurs étrangers emmenée parMediterrania Capital Partners et composé trois autres institutions de développement européenne, notamment DEG, Proparco et FMO.
12-05-2023; Financial Afrik
Mediterrania Capital Partners, une société de gestion de capital-investissement dédiée aux entreprises de mid-market en Afrique du Nord et Subsaharienne, a le plaisir d’annoncer sa prise de participation dans Laprophan – l’un des leaders de l’industrie pharmaceutique au Maroc – via son fonds MC IV, aux côtés de l’institution financière de développement allemande DEG, de Proparco et de FMO.
12-05-2023; Private Equity Wire
Mediterrania Capital Partners, a private equity firm focused on growth investments for SMEs and mid-cap companies in North Africa and Sub-Saharan countries, has acquired a stake in Moroccan pharmaceutical company Laprophan through its fund MC IV, alongside Germany’s development finance institution DEG, Proparco and FMO.
11-05-2023; Casablanca. Mediterrania Capital Partners, a Private Equity firm focused on growth investments for SMEs and mid-cap companies in North Africa and Sub-Saharan countries, is pleased to announce its acquisition of a stake in Laprophan – one of the leading pharmaceutical companies in Morocco –through its fund MC IV, alongside Germany’s development...
1-05-2023; Africa Capital Digest
Mediterrania Capital Partners has taken another step forward in its fundraising march towards the final close for its fourth and largest private equity fund, winning a commitment from an investor in two of the fund manager’s earlier funds.
28-04-2023; HR World The Middle East
Ray Lab, owned by a consortium of investors led by Mediterrania Capital Partners, recently announced the appointment of Hussein El-Ashmawi as the Group Chief Human Resources Officer for KSA, Egypt and Jordan.
23-04-23; LesÉco
La Société financière internationale (SFI) vient de signer un accord portant sur 25 millions d’euros à injecter dans le quatrième véhicule d’investissement de Mediterrania capital partners (MCP).
